ArticleInvestigational new drugs2021

Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells.

Ahmed Elgehama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.